Pembrolizumab as second-line therapy for advanced urothelial carcinoma

Joaquim Bellmunt, Ronald de Wit, David J. Vaughn, Yves Fradet, Jae-Lyun Lee, Lawrence Fong, Nicholas J. Vogelzang, Miguel A. Climent, Daniel P. Petrylak, Toni K. Choueiri, Andrea Necchi, Winald Gerritsen, Howard Gurney, David I. Quinn, Stéphane Culine, Cora N. Sternberg, Yabing Mai, Christian H. Poehlein, Rodolfo F. Perini, Dean F. Bajorin

Research output: Contribution to journalArticle

1266 Citations (Scopus)

Fingerprint Dive into the research topics of 'Pembrolizumab as second-line therapy for advanced urothelial carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences